NetworkNewsBreaks Archive - Page 313 of 2227

MondayMar 17, 2025 11:04 am

NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) to Present at 37th Annual ROTH Conference

FingerMotion (NASDAQ: FNGR), a mobile services, data, and technology company, announced its participation in the 37th Annual ROTH Conference, scheduled for March 16-18, 2025, at The Laguna Cliffs Marriott in Dana Point, California. The event will feature 1-on-1 and small group meetings, fireside chats, industry panels, and keynotes, bringing together executives from approximately 450 private and public companies across various growth sectors. FingerMotion’s management team is available for investor meetings through the conference portal. To view the full press release, visit https://nnw.fm/OKkjv About FingerMotion Inc. FingerMotion is an evolving technology company with a core competency in mobile payment and recharge…

MondayMar 17, 2025 9:05 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Present at BIO-Europe Spring 2025

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and contract development and manufacturing (CDMO) services, announced its participation in the BIO-Europe Spring 2025 conference from March 17-19 in Milan, Italy. The company’s leadership will meet with potential pharmaceutical partners, prospective CDMO clients, and institutional investors to showcase its innovative NanoAb pipeline and biologics manufacturing capabilities. Scinai will also exhibit its CDMO services at booth #22. To view the full press release, visit https://nnw.fm/tIuQa About Scinai Immunotherapeutics Ltd. Scinai is a biopharmaceutical company with two complementary business units. One is focused on in-house development…

FridayMar 14, 2025 3:48 pm

NetworkNewsBreaks – Adageis’ AI-Driven Approach: A Game-Changer in Efficient, Patient-Centered Healthcare

Adageis was featured in a recent article that discussed how its ProActive Care approach shifts healthcare from reactive to preventive, patient-centered care by leveraging AI-driven analytics to identify high-risk patients and address care gaps. This model enhances patient outcomes by focusing on early intervention, care coordination, more time with doctors to focus on patient needs, and better overall health management. For healthcare providers, it boosts operational efficiency and revenue potential through optimizing workflows, meeting value-based care metrics, and minimizing administrative burdens. With the ability to integrate seamlessly with major electronic health record (“EHR”) systems, Adageis’ platform supports providers in delivering more…

FridayMar 14, 2025 3:31 pm

NetworkNewsBreaks – Calidi Biotherapeutics Inc.’s (NYSE American: CLDI) Novel Therapies Show Promise Against Aggressive Cancers

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company that is pioneering proprietary technology designed to attack solid tumors, empowering the immune system to combat cancer. The company was featured in a recent article that discussed its platform, which utilizes antitumor virotherapies that selectively infect and kill cancer cells while stimulating the body’s immune response. Calidi’s pipeline includes three key therapies — RTNova, SuperNova and NeuroNova — that incorporate advanced technologies such as stem cells and antitumor viruses to target and destroy cancer cells. Calidi Biotherapeutics’ innovative therapies hold the potential to revolutionize cancer treatment by enhancing efficacy and stimulating…

FridayMar 14, 2025 1:05 pm

NetworkNewsBreaks – Fifty 1 Labs Inc. (FITY) Achieves Key Milestone in Solidifying Brand, Moves Toward Regaining 15c211 Compliance

Fifty 1 Labs (OTC: FITY), formerly Consumer Automotive Finance Inc. (OTC: CAFI), has successfully completed its name and ticker symbol change, now officially trading as FITY on the OTC market. This marks a significant milestone as the company continues executing its strategic growth initiatives. In addition, the company has responded to a second round of comments in its ongoing efforts to regain compliance with SEC Rule 15c2-11. "We are excited about the progress we've made in solidifying our brand identity and strengthening our market position," said Brandon Spikes, CEO of Fifty 1 Labs. "Finalizing our name and symbol change represents…

FridayMar 14, 2025 12:58 pm

NetworkNewsBreaks – Upstream Disrupting Stock Trading with Blockchain-Powered Execution

Upstream published a blog that discusses the financial world’s embracement of blockchain-powered trading. While many traditional stock markets operate on legacy infrastructure, Upstream is revolutionizing trading by leveraging blockchain technology to provide real-time execution, instant settlement, and global access without typical barriers. Unlike conventional stock markets that have longer settlement times and limited trading hours, Upstream allows investors to trade 20 hours a day, seven days a week, with instant transactions executed transparently on a decentralized ledger. Its platform offers a more accessible, efficient and fair trading experience, powering the future of stock trading today. To view the full blog,…

FridayMar 14, 2025 10:24 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q4 and Full-Year 2024 Financial Results, Highlights FDA Clearance and Commercial Progress

HeartBeam (NASDAQ: BEAT), a medical technology company focused on advanced cardiac care, announced its financial and operational results for the fourth quarter and full-year 2024. The company achieved key milestones, including FDA 510(k) clearance for the HeartBeam System, the launch of an Early Access Program to refine its clinical workflow, and the submission of an FDA application for its 12-lead ECG synthesis software. HeartBeam also raised $11.5 million in gross proceeds from a public offering to support commercialization efforts. Financially, research and development expenses rose to $11.1 million in 2024 from $6.8 million in 2023, while net loss widened to…

FridayMar 14, 2025 10:12 am

NetworkNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Reschedules Full-Year 2024 Financial Results Release to March 24

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, has rescheduled the release of its financial results for the year ended Dec. 31, 2024, to before market open on March 24, 2025. The company’s leadership team, including Executive Chairman and CEO Charles M. Fernandez, CFO Cecile Munnik, and President and CEO of Global Operations David Phipps, will host a conference call at 8:30 a.m. Eastern on the same day to discuss the results and recent developments. Investors are encouraged to submit questions for the Q&A session before March 18. To view the full press release, visit https://nnw.fm/47pbh About NextPlat Corp NextPlat…

FridayMar 14, 2025 9:00 am

NetworkNewsBreaks – Nicola Mining Inc. (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) Secures Final Permit for Bulk Sampling at Dominion Creek, Closes $1.13M Financing

Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) has received the Final Permit to conduct a bulk sample at its Dominion Creek Mineral Project, a high-grade gold and silver property in which the company holds a 75% economic interest. The permit, effective until Feb. 27, 2030, allows Nicola and partner High Range Exploration Ltd. to extract ore before transitioning to reclamation. The company also obtained a Free Use Permit to upgrade a haul road for ore transport. Additionally, Nicola closed a non-brokered private placement, issuing 4,038,955 units for gross proceeds of approximately $1.13 million, with net proceeds of $1.07 million…

FridayMar 14, 2025 8:30 am

NetworkNewsBreaks – D-Wave Reports Fourth Quarter and Year-End 2024 Results

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has announced its financial results for fourth quarter and year-end 2024, with a 128% year-over-year increase in bookings, reaching $23.9 million in bookings for the year ended December 31, 2024. The company also announced a consolidated cash balance that now exceeds $300 million. "Every day D-Wave’s quantum technology is helping customers gain competitive advantages, discover new scientific breakthroughs, and fuel innovations that were previously unimaginable," said Dr. Alan Baratz, CEO of D-Wave. "Our mission is unwavering - to help organizations realize the benefits of quantum…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks